إعلان
إعلان

MLAB

MLAB logo

Mesa Laboratories Inc

81.19
USD
برعاية
-3.17
-3.76%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

81.19

0.00
0.00%

تقارير أرباح MLAB

النسبة الإيجابية المفاجئة

MLAB تفوق 19 من 39 آخر التقديرات.

49%

التقرير التالي

بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q3 26 (Revenue/ EPS)
$64.63M
/
$0.28
التغير الضمني من Q2 26 (Revenue/ EPS)
+6.40%
/
-37.78%
التغير الضمني من Q3 25 (Revenue/ EPS)
+2.84%
/
-212.00%

Mesa Laboratories Inc earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, MLAB reported earnings of 0.45 USD per share (EPS) for Q2 26, beating the estimate of 0.16 USD, resulting in a 175.74% surprise. Revenue reached 60.74 مليون, compared to an expected 61.95 مليون, with a -1.95% difference. The market reacted with a +1.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 المحللين forecast an EPS of 0.28 USD, with revenue projected to reach 64.63 مليون USD, implying an نقصان of -37.78% EPS, and زيادة of 6.40% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q2 2026, Mesa Laboratories Inc reported EPS of $0.45, beating estimates by 175.74%, and revenue of $60.74M, -1.95% below expectations.
The stock price moved up 1.52%, changed from $74.87 before the earnings release to $76.01 the day after.
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
Based on 5 المحللين, Mesa Laboratories Inc is expected to report EPS of $0.28 and revenue of $64.63M for Q3 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان